234 related articles for article (PubMed ID: 35691019)
21. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
[TBL] [Abstract][Full Text] [Related]
22. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
23. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
24. Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation.
Baghdasaryan A; Claudel T; Kosters A; Gumhold J; Silbert D; Thüringer A; Leski K; Fickert P; Karpen SJ; Trauner M
Gut; 2010 Apr; 59(4):521-30. PubMed ID: 20332524
[TBL] [Abstract][Full Text] [Related]
25. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.
Hintermann E; Tondello C; Fuchs S; Bayer M; Pfeilschifter JM; Taubert R; Mollenhauer M; Elferink RPJO; Manns MP; Christen U
J Autoimmun; 2024 Jun; 146():103229. PubMed ID: 38653165
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis.
Liu T; Wang RX; Han J; Li ZD; Sheps JA; Zheng LJ; Xu XX; Ling V; Wang JS
J Clin Transl Hepatol; 2024 Feb; 12(2):151-161. PubMed ID: 38343606
[TBL] [Abstract][Full Text] [Related]
27. Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism.
Li J; Zhu X; Zhang M; Zhang Y; Ye S; Leng Y; Yang T; Kong L; Zhang H
J Hepatol; 2021 Aug; 75(2):400-413. PubMed ID: 33746084
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Stiedl P; McMahon R; Blaas L; Stanek V; Svinka J; Grabner B; Zollner G; Kessler SM; Claudel T; Müller M; Mikulits W; Bilban M; Esterbauer H; Eferl R; Haybaeck J; Trauner M; Casanova E
Hepatology; 2015 Feb; 61(2):613-26. PubMed ID: 25179284
[TBL] [Abstract][Full Text] [Related]
32. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4
Krishnan A; Katsumi T; Guicciardi ME; Azad AI; Ozturk NB; Trussoni CE; Gores GJ
Am J Pathol; 2020 Jun; 190(6):1284-1297. PubMed ID: 32240619
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice.
Miethke AG; Zhang W; Simmons J; Taylor AE; Shi T; Shanmukhappa SK; Karns R; White S; Jegga AG; Lages CS; Nkinin S; Keller BT; Setchell KD
Hepatology; 2016 Feb; 63(2):512-23. PubMed ID: 26172874
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
[TBL] [Abstract][Full Text] [Related]
35. Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice.
Kunst RF; de Waart DR; Wolters F; Duijst S; Vogels EW; Bolt I; Verheij J; Beuers U; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 Nov; 4(11):100573. PubMed ID: 36160754
[TBL] [Abstract][Full Text] [Related]
36. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
Svinka J; Pflügler S; Mair M; Marschall HU; Hengstler JG; Stiedl P; Poli V; Casanova E; Timelthaler G; Sibilia M; Eferl R
J Mol Med (Berl); 2017 Jan; 95(1):109-117. PubMed ID: 27568040
[TBL] [Abstract][Full Text] [Related]
38. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
39. All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.
Cai SY; Mennone A; Soroka CJ; Boyer JL
J Pharmacol Exp Ther; 2014 Apr; 349(1):94-8. PubMed ID: 24492652
[TBL] [Abstract][Full Text] [Related]
40. Targeted Apoptosis of Ductular Reactive Cells Reduces Hepatic Fibrosis in a Mouse Model of Cholestasis.
Azad AI; Krishnan A; Troop L; Li Y; Katsumi T; Pavelko K; Kostallari E; Guicciardi ME; Gores GJ
Hepatology; 2020 Sep; 72(3):1013-1028. PubMed ID: 32128842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]